about
Present and future challenges in the treatment of haemophilia: the patient's perspectivePulmonary Arteriovenous Malformations and Cerebral Abscess Recurrence in a Child With Hereditary Hemorrhagic Telangiectasia.Clinical Data of Neonatal Systemic Thrombosis.Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment.Splenectomy in children with chronic ITP: long-term efficacy and relation between its outcome and responses to previous treatments.Management of acute childhood idiopathic thrombocytopenic purpura according to AIEOP consensus guidelines: assessment of Italian experience.Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.Hepatic veno-occlusive disease during chemotherapy for nephroblastoma: successful and safe treatment with defibrotide. Report of a clinical case.Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines.Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study.Langerhans cell histiocytosis in a pediatric patient with thrombocytopenia-absent radius syndrome and 1q21.1 deletion: case report and proposal of a rapid molecular diagnosis of 1q21.1 deletion.Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura.Thrombocytopenia-absent-radius syndrome in a child showing a larger 1q21.1 deletion than the one in his healthy mother, and a significant downregulation of the commonly deleted genes.Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura.Vaccine administration and the development of immune thrombocytopenic purpura in childrenPlatelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life studyAutoimmune haematological disorders in two Italian children with Kabuki syndromeChronic immune thrombocytopenia in childhood.ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's.Efficacy of combined intravenous immunoglobulins and steroids in children with primary immune thrombocytopenia and persistent bleeding symptomsB-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.A volleyball player with bilateral knee osteochondritis dissecans treated with extracorporeal shock wave therapy.Mutational screening of thrombopoietin receptor gene (c-mpl) in patients with congenital thrombocytopenia and absent radii (TAR).Uncovered needs in the management of inherited bleeding disorders in Italy.Clinical and laboratory characteristics of children positive for antiphospholipid antibodies.Management of liver disease in thalassemia: main drug targets for a correct therapy.HHT in childhood: screening for special patients.Risk factors for subclinical atherosclerosis in diabetic and obese children.Issues in pediatric haemophilia careManagement and investigation of neonatal thromboembolic events: genetic and acquired risk factors.Venous thrombosis in children: an emerging issue.Catheter-related infections in pediatric patients with cancer.Carotenoids and cardiovascular risk.Respiratory epithelial imbalances in asthma pathophysiology.Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP).Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis.A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns.Elevated endothelin-1 (ET-1) levels may contribute to hypoadiponectinemia in childhood obesity.Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supporti
P50
Q27022801-5F77C3F1-F861-4465-A869-3EC44774B1F5Q30851171-B47A2B03-F7A3-41F8-AB9A-0548E62AC224Q31038268-6C0EE3F4-2421-4C24-9C01-F61942DB9491Q33372069-155978E0-908F-4806-B6CB-990A1E80AF35Q33372385-132606F5-B9E7-472D-8875-3FB59F433128Q33378160-3EF383DA-8F7B-42ED-B60D-1A1F69EB3B88Q33382172-17FD5DD5-A221-4070-A3F2-26A0F6688314Q33386854-322715DD-0E8E-4987-8297-CAE34782CD2DQ33387589-9DD38587-8883-40AB-A65A-135383B834CCQ33391827-353FBCC8-0ABB-447C-A9AD-2842F4BD1716Q33394614-13FBB194-EF59-4DD5-A3CC-E53B98E346ABQ33398637-72C8D404-04CA-4321-8EB6-00EBAF7C9DBBQ33398925-28C4B3E7-890D-4606-AB11-F4A2FDF9FFA6Q33401688-62FBFB70-FDB2-4489-866C-89BD4423FA4CQ33405328-B4E7C067-1BB9-485B-9960-85AE3232EA7AQ33407292-FB16AF0D-FBB2-450B-BFB6-4D7F8BCBCF3AQ33412879-377037CF-9294-477F-8B1C-E75B222F7EDBQ33413113-2E202604-D0E3-48A2-A36C-3DD8B1C5F062Q33415460-407D37A2-9100-44B5-A407-45B95FB598DBQ33415659-F16A9497-DE69-4E2D-A533-DB575466BAE0Q33426961-897D5FBB-61D6-43A2-BFAB-6A57FFF5A41CQ33497369-7E02E664-DA0D-415A-A515-F80345A0F207Q33504447-A9CE1C4E-9855-4965-BE76-6F11D1068B72Q33708980-CA594FC5-541E-4A4B-9C8B-B929F513B41CQ36159957-29392433-32EF-4385-86FB-8EEEE323D324Q36352231-E18FA06E-ACAC-437B-98AD-3781DECEE552Q36447298-7D46EC5B-D252-4910-B578-0F80375642FAQ36619217-1C68A7EF-8AE4-4F3E-A34C-020844071CB5Q36835166-170DC152-AE37-4C57-9D52-607A655898ACQ37376571-A12DFA86-B1A0-46F2-8BF6-926AA6C1D917Q37890817-913A043D-43F6-4C19-869B-E9DAE533639DQ38015749-49807AFA-B0C8-4C1E-8C4D-37718BDD3365Q38022707-2245D167-D104-4671-B9CC-2B5D8F55D468Q38088787-7D6C9D12-8613-467E-88EF-3E359DA9CC37Q38101788-5E083B11-03D8-40FD-B176-BA3383CA54FCQ38114828-B21332F6-D5B6-48AD-8221-F09FE657E3C5Q38227605-45E11BA5-822B-4AC1-BF9E-E2BFACECD563Q38261097-EBBA79D0-E3B6-4C7D-9360-A34DD617314FQ38317347-48F4DEA5-F692-44DA-8231-48818EE4FD5EQ38572306-6E87269D-0E34-4E8C-B88E-7D7C3A8BEFE8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paola Giordano
@ast
Paola Giordano
@en
Paola Giordano
@es
Paola Giordano
@nl
Paola Giordano
@sl
type
label
Paola Giordano
@ast
Paola Giordano
@en
Paola Giordano
@es
Paola Giordano
@nl
Paola Giordano
@sl
altLabel
Giordano P
@en
prefLabel
Paola Giordano
@ast
Paola Giordano
@en
Paola Giordano
@es
Paola Giordano
@nl
Paola Giordano
@sl
P106
P1153
7102002793
P21
P31
P496
0000-0002-7762-3500